CHIL’s High-Risk Group EIA Kits Recognized as Reference Assays in KSA Screening Program

CHIL’s high-risk group HIVAb, HBsAg, and HCVAb Enzyme Immunoassay (EIA) diagnostic kits have gained recognition as reference assays within a screening program in the Kingdom of Saudi Arabia.

Following their introduction into the market, the consistent performance and reliability of the products have led healthcare professionals to regard them as benchmark assays within the scope of regulated screening procedures. This development reflects the confidence established in a newly entered market and marks an important step in CHIL’s regional expansion.